[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JPS56108716A - Antiviral agent containing different kind dead cell mixture as effective component - Google Patents

Antiviral agent containing different kind dead cell mixture as effective component

Info

Publication number
JPS56108716A
JPS56108716A JP873080A JP873080A JPS56108716A JP S56108716 A JPS56108716 A JP S56108716A JP 873080 A JP873080 A JP 873080A JP 873080 A JP873080 A JP 873080A JP S56108716 A JPS56108716 A JP S56108716A
Authority
JP
Japan
Prior art keywords
dead cell
cell mixture
antiviral agent
agent
antiviral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP873080A
Other languages
Japanese (ja)
Other versions
JPS6234725B2 (en
Inventor
Shuji Ando
Akiji Kuwayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanwa Kagaku Kenkyusho Co Ltd
Original Assignee
Sanwa Kagaku Kenkyusho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanwa Kagaku Kenkyusho Co Ltd filed Critical Sanwa Kagaku Kenkyusho Co Ltd
Priority to JP873080A priority Critical patent/JPS56108716A/en
Publication of JPS56108716A publication Critical patent/JPS56108716A/en
Publication of JPS6234725B2 publication Critical patent/JPS6234725B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PURPOSE: An antiviral agent that is composed of a dead cell mixture of 8 different kinds of specific bacteria.
CONSTITUTION: The antiviral agent contains a dead cell mixture of Pneumococcus, hemolytic Streptococcus, Staphylococcus, Neisseria catarrhalis, Gaffkya tetragena, Pseudomonas aeruginosa, Pneumobacillus and Influenza bacillus as effective components. The dead cell mixture has been known as an antitumor agent or a remedy for bronchial asthma, however, it has been found to be also useful as a remedy for viral diseases. In the preparation of the agent, each bacterium is cultured separately, cell bodies are collected and killed by heating. The dead cells are disinfected with formalin and suspended in a physiological salt solution to prepare the dead cell base solution. The resultant base solutions are mixed to form, e.g., an injection solution, which is used as an antiviral preparation.
COPYRIGHT: (C)1981,JPO&Japio
JP873080A 1980-01-30 1980-01-30 Antiviral agent containing different kind dead cell mixture as effective component Granted JPS56108716A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP873080A JPS56108716A (en) 1980-01-30 1980-01-30 Antiviral agent containing different kind dead cell mixture as effective component

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP873080A JPS56108716A (en) 1980-01-30 1980-01-30 Antiviral agent containing different kind dead cell mixture as effective component

Publications (2)

Publication Number Publication Date
JPS56108716A true JPS56108716A (en) 1981-08-28
JPS6234725B2 JPS6234725B2 (en) 1987-07-28

Family

ID=11701062

Family Applications (1)

Application Number Title Priority Date Filing Date
JP873080A Granted JPS56108716A (en) 1980-01-30 1980-01-30 Antiviral agent containing different kind dead cell mixture as effective component

Country Status (1)

Country Link
JP (1) JPS56108716A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024420A1 (en) * 1998-10-28 2000-05-04 Sonntag Hans Guenter Method for the production of an antiviral agent
JP2012097112A (en) * 2004-06-07 2012-05-24 Qu Biologics Inc Bacterial composition for the treatment of cancer
US8980279B2 (en) 2010-07-26 2015-03-17 Qu Biologics Personalized site-specific immunomodulation
US9107864B2 (en) 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US9320787B2 (en) 2004-06-07 2016-04-26 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US10130692B2 (en) 2010-07-26 2018-11-20 Qu Biologics Inc. Immunogenic anti-inflammatory compositions
US10251946B2 (en) 2014-05-02 2019-04-09 Qu Biologics Inc. Anti-microbial immunomodulation

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024420A1 (en) * 1998-10-28 2000-05-04 Sonntag Hans Guenter Method for the production of an antiviral agent
US9320787B2 (en) 2004-06-07 2016-04-26 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US9107864B2 (en) 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
JP2015157848A (en) * 2004-06-07 2015-09-03 クー バイオロジックス インク．Ｑｕ Ｂｉｏｌｏｇｉｃｓ Ｉｎｃ． Bacterial compositions for treating cancer
JP2016006084A (en) * 2004-06-07 2016-01-14 クー バイオロジックス インク．Ｑｕ Ｂｉｏｌｏｇｉｃｓ Ｉｎｃ． Bacterial composition for treating cancer
JP2012097112A (en) * 2004-06-07 2012-05-24 Qu Biologics Inc Bacterial composition for the treatment of cancer
US9320788B2 (en) 2004-06-07 2016-04-26 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US9775896B2 (en) 2004-06-07 2017-10-03 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US10086066B2 (en) 2004-06-07 2018-10-02 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US8980279B2 (en) 2010-07-26 2015-03-17 Qu Biologics Personalized site-specific immunomodulation
US10130692B2 (en) 2010-07-26 2018-11-20 Qu Biologics Inc. Immunogenic anti-inflammatory compositions
US10251946B2 (en) 2014-05-02 2019-04-09 Qu Biologics Inc. Anti-microbial immunomodulation
US10946083B2 (en) 2014-05-02 2021-03-16 Qu Biologies Inc. Anti-microbial immunomodulation
US11819543B2 (en) 2014-05-02 2023-11-21 Qu Biologics Inc. Anti-microbial immunomodulation

Also Published As

Publication number Publication date
JPS6234725B2 (en) 1987-07-28

Similar Documents

Publication Publication Date Title
JPS5672695A (en) Preparation of l-leucine
CA2095854A1 (en) Mycobacterium vaccae in the treatment of uveitis
FR2387980A1 (en) NEW 2- (2,2-DIARYLALKYL) -1-AZABICYCLO (2.2.2) OCTANES, USEFUL IN PARTICULAR AS ANTIDIARRHEA, AND THEIR PREPARATION PROCESS
DE3369158D1 (en) Biologically active ws 6049 substances, a process for the production thereof and their pharmaceutical compositions
JPS56108716A (en) Antiviral agent containing different kind dead cell mixture as effective component
JPS5299289A (en) Preparation of l-arginine by fermentation
JPS5391189A (en) Preparation of d-n-carbamoyl-alpha-amino acids
JPS5381691A (en) Preparation of l-serine
JPS53145984A (en) Preparation of vitamin b12 by fermentation
FI922874A (en) AMONOMETHYL SUBSTRATES 2,3-DIHYDROPYRANO / 2,3-B / PYRIDINER, FOERFARANDEFOER FRAMSTAELLNING AV DESSA OCH ANVAENDNING AV DESSA I CEILING MODEL
JPS52108088A (en) Preparation of monohydroxycarboxylic acid using microbials
JPS5528A (en) Preparation of coenzyme q9
JPS5428893A (en) Preparation of sarcosine oxidase
JPS542398A (en) Preparation of d-alpha-amino acid
JPS5618924A (en) Infection prophylactic and remedy containing a dead cell mixture of different kinds of bacteria as the effective component
JPS5417182A (en) Preparation of choline-oxidase
JPS52134094A (en) Preparation of pseudo-oxynicotine
JPS5452791A (en) Preparation of d-alpha-amino acid
JPS5423194A (en) Preparation of inosine-5'-monophosphate
JPS53113093A (en) Preparation of physiological active agent p9-12
JPS5417183A (en) Preparation of l-glutamic acid
JPS5386080A (en) Cultivation of microorganisms
JPS5391190A (en) Preparation of 5'-ribonucleoside
JPS52156995A (en) Microbial preparation of l-lysine
Crookes On Metallic Colloids and Their Bactericidal Properties